Business & Economy · 20 views
OKYO Pharma appoints Leerink Partners as sales agent for ATM equity offering
OKYO Pharma Ltd (NASDAQ:OKYO) a clinical-stage biopharmaceutical company focused on therapies for neuropathic corneal pain and inflammato…
Source finance.yahoo.com Story Brief Updated February 12, 2026
Business & Economy 
Story intelligence Beta
Confidence Limited Single-outlet story
Views 20 Community interest
Story Brief
OKYO Pharma Ltd (NASDAQ:OKYO) a clinical-stage biopharmaceutical company focused on therapies for neuropathic corneal pain and inflammatory eye diseases, announced that it has transitioned its At-The-Market (ATM) equity
Read full article on FinanceAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
Part of ATM coverage 8 tracked stories
Explore ATM More from Business & Economy
Continue reading recent Business & Economy coverage
- 'They asked too much': Canadian dollar slides as Ottawa and Washington head for all-out trade warContinue reading
- There are six stocks that hedge funds and mutual funds are both overweight — and SpaceX is oneContinue reading
- Bessent could tap near $1 trillion Treasury General Account to fund bond buybacks, sources saidContinue reading
- Research Firm’s Founder Explains $6 Million Payment to Fired Forbes EditorContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow